203 related articles for article (PubMed ID: 23370134)
1. Shared REMS programs expanded in 2012.
Traynor K
Am J Health Syst Pharm; 2013 Feb; 70(4):298, 303. PubMed ID: 23370134
[No Abstract] [Full Text] [Related]
2. Where are risk evaluation and mitigation strategies headed?
Johnson PE
Am J Health Syst Pharm; 2010 Sep; 67(18):1511. PubMed ID: 20811027
[No Abstract] [Full Text] [Related]
3. Risk evaluation and mitigation strategies: challenges and opportunities for health-system pharmacists.
Stubbings J; Joshi RA; Hoffman JM
Am J Health Syst Pharm; 2010 Sep; 67(18):1547-54. PubMed ID: 20811034
[No Abstract] [Full Text] [Related]
4. Issues related to risk evaluation and mitigation strategies in health-system pharmacy.
Coffey J
Am J Health Syst Pharm; 2010 Sep; 67(18):1512. PubMed ID: 20811028
[No Abstract] [Full Text] [Related]
5. APhA 2011 REMS white paper: Summary of the REMS stakeholder meeting on improving program design and implementation.
American Pharmacists Association ; Bough M
J Am Pharm Assoc (2003); 2011; 51(3):340-58. PubMed ID: 21555285
[TBL] [Abstract][Full Text] [Related]
6. With REMS, what goes up can come down.
Thompson CA
Am J Health Syst Pharm; 2011 May; 68(9):783-4. PubMed ID: 21515857
[No Abstract] [Full Text] [Related]
7. 'Dear Healthcare Professional' letters may not be effective REMS communication tool.
Thompson CA
Am J Health Syst Pharm; 2014 Feb; 71(3):177-8. PubMed ID: 24429006
[No Abstract] [Full Text] [Related]
8. Medication guides leave their REMS programs behind.
Traynor K
Am J Health Syst Pharm; 2012 Feb; 69(4):272-3. PubMed ID: 22302249
[No Abstract] [Full Text] [Related]
9. The Food and Drug Administration risk evaluation and mitigation strategy.
Craig DS
J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):145-8. PubMed ID: 20504137
[TBL] [Abstract][Full Text] [Related]
10. The Food and Drug Administration Amendments Act of 2007: drug safety and health-system pharmacy implications.
Meyer BM
Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S3-5. PubMed ID: 19966078
[TBL] [Abstract][Full Text] [Related]
11. Risk evaluation and mitigation strategies: impact on patients, health care providers, and health systems.
Shane R
Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S6-S12. PubMed ID: 19966079
[TBL] [Abstract][Full Text] [Related]
12. Examination of risk evaluation and mitigation strategies and drug safety in the US.
Rodriguez-Monguio R; Spielberger K; Seoane-Vazquez E
Res Social Adm Pharm; 2014; 10(1):232-8. PubMed ID: 23611865
[TBL] [Abstract][Full Text] [Related]
13. New botulinum toxin approved with REMS.
Thompson CA
Am J Health Syst Pharm; 2010 Sep; 67(18):1486. PubMed ID: 20811019
[No Abstract] [Full Text] [Related]
14. The US Food and Drug Administration's Risk Evaluation and Mitigation Strategy (REMS) Program - Current Status and Future Direction.
Wu J; Juhaeri J
Clin Ther; 2016 Dec; 38(12):2526-2532. PubMed ID: 27914632
[TBL] [Abstract][Full Text] [Related]
15. Pediatric information in drug product labeling.
Sachs AN; Avant D; Lee CS; Rodriguez W; Murphy MD
JAMA; 2012 May; 307(18):1914-5. PubMed ID: 22570457
[No Abstract] [Full Text] [Related]
16. Class-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.
Matthews ML
J Am Pharm Assoc (2003); 2013; 53(1):e1-7. PubMed ID: 23636166
[TBL] [Abstract][Full Text] [Related]
17. What can be done to improve confidence and trust in the safety of the system for pharmaceutical products?
Edwards BD; Whalen MD; Powell SM
Curr Drug Saf; 2013 Feb; 8(1):1-3. PubMed ID: 23713998
[No Abstract] [Full Text] [Related]
18. FDA's sentinel network: a monumental task.
Young D
Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
[No Abstract] [Full Text] [Related]
19. Food and Drug Administration's Safe Use Initiative collaborating to reduce preventable harm from medications.
U S Food And Drug Administration
J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):76-93. PubMed ID: 20345207
[No Abstract] [Full Text] [Related]
20. How the FDA handles GI drug safety.
Lewis JH
Am J Gastroenterol; 2012 Aug; 107(8):1264; author reply 1264-5. PubMed ID: 22859005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
